Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging

Journal of Clinical Oncology

Volumn 29, Issue 13, 2011, Pages 1664-1669

  Warner, Ellen ^a,b,c,d,e   Hill, Kimberley ^a,b,c,d,e   Causer, Petrina ^a,b,c,d,e   Plewes, Donald ^a,b,c,d,e   Jong, Roberta ^a,b,c,d,e   Yaffe, Martin ^a,b,c,d,e   Foulkes, William D ^a,b,c,d,e   Ghadirian, Parviz ^a,b,c,d,e   Lynch, Henry ^a,b,c,d,e   Couch, Fergus ^a,b,c,d,e   Wong, John ^a,b,c,d,e   Wright, Frances ^a,b,c,d,e   Sun, Ping ^a,b,c,d,e   Narod, Steven A ^a,b,c,d,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; ESTROGEN RECEPTOR; GADODIAMIDE; TAMOXIFEN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BREAST CANCER; BREAST EXAMINATION; CANADA; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER SCREENING; CANCER STAGING; CLINICAL PROTOCOL; COHORT ANALYSIS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ECHOMAMMOGRAPHY; FEMALE; FOLLOW UP; GENE MUTATION; HAZARD RATIO; HORMONE SUBSTITUTION; HUMAN; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTECTOMY; METASTASIS; MUTATIONAL ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; TUMOR VOLUME;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; EARLY DETECTION OF CANCER; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MUTATION;

EID: 79955638821     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.27.0835     Document Type: Article

References (16)

1. Ford D, Easton DF, Stratton M, et al: Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families: The Breast Cancer Linkage Consortium. Am J Hum Genet 62:676-689, 1998 (Pubitemid 28164626)
2. Saslow D, Boetes C, Burke W, et al: American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57:75-89, 2007 (Pubitemid 46535708)
3. Warner E, Plewes DB, Hill KA, et al: Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292:1317-1325, 2004 (Pubitemid 39223222)
4. Leach MO, Boggis CR, Dixon AK, et al: Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: A prospective multicentre cohort study (MARIBS). Lancet 365:1769-1778, 2005 (Pubitemid 40744657)
5. Kriege M, Brekelmans CT, Boetes C, et al: Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351:427-437, 2004
6. Warner E, Messersmith H, Causer P, et al: Systematic review: Using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med 148:671-679, 2008 (Pubitemid 351669112)
7. American College of Radiology: Breast Imaging Reporting and Data System (BI-RADS; ed 2). Reston, VA, American College of Radiology, 1993, pp 15-18
8. Pintilie M: Competing Risks: A Practical Perspective. Hoboken, New Jersey, Wiley, 2002
9. Pepe MS, Mori M: Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Stat Med 12:737-751, 1993
10. Brekelmans CT, Seynaeve C, Bartels CC, et al: Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. J Clin Oncol 19:924-930, 2001 (Pubitemid 32176266)
11. Scheuer L, Kauff N, Robson M, et al: Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol 20:1260-1268, 2002 (Pubitemid 34177432)
12. Komenaka IK, Ditkoff BA, Joseph KA, et al: The development of interval breast malignancies in patients with BRCA mutations. Cancer 100:2079-2083, 2004 (Pubitemid 38580324)
13. Vasen HF, Tesfay E, Boonstra H, et al: Early detection of breast and ovarian cancer in families with BRCA mutations. Eur J Cancer 41:549-554, 2005 (Pubitemid 40292734)
14. Kuhl CK, Schmutzler RK, Leutner CC, et al: Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: Preliminary results. Radiology 215:267-279, 2000 (Pubitemid 30190541)
15. Kuhl CK, Schrading S, Leutner CC, et al: Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 23:8469-8476, 2005
16. Tilanus-Linthorst MM, Obdeijn IM, Hop WC, et al: BRCA1 mutation and young age predict fast breast cancer growth in the Dutch, United Kingdom, and Canadian magnetic resonance imaging screening trials. Clin Cancer Res 13:7357-7362, 2007